ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Session » Fibromyalgia & Other Clinical Pain Syndromes Poster

Date: Sunday, November 10, 2019

Time: 9:00AM-11:00AM

Meeting: 2019 ACR/ARP Annual Meeting

9:00AM-11:00AM
Abstract Number: 219
A Fibromyalgia Assessment Screening Tool on a Multidimensional Health Assessment Questionnaire (MDHAQ) Which Does Not Include a Self-Report RADAI Painful Joint Count (RADAI), FAST3nJC, Recognizes Fibromyalgia Similarly to Other FAST3 Indices Which Include a RADAI
9:00AM-11:00AM
Abstract Number: 224
A Functional Exercise Program Improves Pain and Health Related Quality of Life in Patients with Fibromyalgia: A Randomized Controllel Trial
9:00AM-11:00AM
Abstract Number: 220
A Positive Response to Nonpharmacological Therapies in Patients with Fibromyalgia
9:00AM-11:00AM
Abstract Number: 222
Acupuncture for Chronic Musculoskeletal Pain: A Review of Randomized Controlled Trials
9:00AM-11:00AM
Abstract Number: 241
Comparing Patients with Fibromyalgia Syndrome with Non-Fibromyalgia Rheumatic Disease Patients Regarding Exercise
9:00AM-11:00AM
Abstract Number: 243
Concomitant Fibromyalgia in Patients with Other Rheumatic Diseases and Response to Treatment
9:00AM-11:00AM
Abstract Number: 223
Correlation Between Heart Rate Variability Parameters and Circulating Neuropeptides in Fibromyalgia
9:00AM-11:00AM
Abstract Number: 237
Determination of Muscle Pressure in Patients with Fibromyalgia by Two Examiners; The Examiners Get Similar Results
9:00AM-11:00AM
Abstract Number: 216
Does Fibromyalgia Change the Evaluation of Spondyloarthritis Activity? A Meta-analysis of Observational Studies
9:00AM-11:00AM
Abstract Number: 231
Duloxetine for Chronic Pain Management in a Tertiary Care Rheumatology Practice: How Patients Are Doing in the Real World
9:00AM-11:00AM
Abstract Number: 211
Effects of Deep Haptic Massage in Fibromyalgia (pilot Study)
9:00AM-11:00AM
Abstract Number: 218
Effects of Tai Chi versus Aerobic Exercise on Mindfulness in Fibromyalgia
9:00AM-11:00AM
Abstract Number: 221
Emergency Department Utilization for Fibromyalgia Patients
9:00AM-11:00AM
Abstract Number: 225
Evaluating Fibromyalgia Symptoms in Transgender Patients
9:00AM-11:00AM
Abstract Number: 217
Fibromyalgia and Multiple Switching of Biologics in Spondylarthritis
9:00AM-11:00AM
Abstract Number: 228
Good Pain, Bad Pain: Illness Perception and Physicians Attitude Towards Rheumatoid Arthritis and Fibromyalgia Patients
9:00AM-11:00AM
Abstract Number: 232
Hand Digital Thermography Findings in Patients with Primary Fibromyalgia
9:00AM-11:00AM
Abstract Number: 214
How Well Do Visual Analogue Scales Used in the Fibromyalgia Impact Questionnaire (FIQ) Correlate with Other Measures of Pain, Fatigue, Sleep, Sleep Disturbance, Anxiety and Depression in Patients with Fibromyalgia
9:00AM-11:00AM
Abstract Number: 226
Hypersensitivity Beyond Pain: Hyperacusis and Hyperalgesia of Patients with Fibromyalgia
9:00AM-11:00AM
Abstract Number: 233
Intensive CBT Is Effective in the Treatment of Significant Functional Impairment and Psychological Distress Found in Fibromyalgia: But Can We Improve Depressive Symptoms?
9:00AM-11:00AM
Abstract Number: 229
Is Fibromyalgia Associated with Structural or Functional Abnormalities in Skeletal Muscle?
9:00AM-11:00AM
Abstract Number: 227
Metabolomic and Symptom Comparison in Women With/without Fibromyalgia: A Pilot Study
9:00AM-11:00AM
Abstract Number: 238
Muscle Pressure as Measured by a Manometer Correlates with Dolorimetry in Patients with Fibromyalgia
9:00AM-11:00AM
Abstract Number: 235
Muscle Pressure Correlates with Pain Levels in Fibromyalgia Patients and Muscle Tension May Be the Cause of Their Pain
9:00AM-11:00AM
Abstract Number: 215
Opioid Treatment Pattern in a Community Based Rheumatology Clinic
9:00AM-11:00AM
Abstract Number: 234
Oxytocin Attenuates Tactile Allodynia in Experimental Fibromyalgia Rats
9:00AM-11:00AM
Abstract Number: 230
Patients with Fibromyalgia Associated with Rheumatoid Arthritis and Patients with Primary Fibromyalgia Differ in Depression, Anxiety, Stress-related Disorders and Events: A Cross-sectional Study
9:00AM-11:00AM
Abstract Number: 213
Relationship Between a History of Abuse and Fibromyalgia Symptoms and Severity: Data from the Cleveland Clinic Fibromyalgia Registry
9:00AM-11:00AM
Abstract Number: 236
Repeat Muscle Pressures Measured in Fibromyalgia Patients and Compared with Pain Scores
9:00AM-11:00AM
Abstract Number: 242
The Effectiveness of Medications for Fibromyalgia Based on Patient Experiences
9:00AM-11:00AM
Abstract Number: 239
The SELENA SLEDAI Is an Imperfect Measure of Lupus Disease Activity in Patients with Concomitant Fibromyalgia
9:00AM-11:00AM
Abstract Number: 212
Utility of Mood Disorders Questionnaire in Fibromyalgia: Data from the Cleveland Clinic Fibromyalgia Registry
9:00AM-11:00AM
Abstract Number: 240
Whom Do Patients with Fibromyalgia Turn to for Emotional Support?

« View all sessions from this meeting

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology